Navigation Links
Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $15 Million of Preferred Stock
Date:4/13/2009

Company Further Simplifies Its Capital Structure By Completing the Elimination of All Previously Outstanding Preferred Stock

SEATTLE, April 13 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (Nasdaq and MTA: CTIC) today announced that it has agreed to sell up to $20 million of Series 1 Preferred Stock and warrants in a registered offering to a single institutional investor. The investor initially purchased today, for $15 million cash, shares of Series 1 Preferred Stock with a stated value of $15 million and certain associated common stock warrants and has the right to, within 60 days, purchase for an additional $5 million cash additional shares of Series 1 Preferred Stock with a stated value of $5 million with no additional warrants. The Series 1 Preferred Stock is convertible into shares of common stock at a conversion price of $0.30. The investor received 45% warrant coverage on the initial $15 million purchase. The warrants have an exercise price of $0.41 per share, for total potential additional proceeds of approximately $9 million. Approximately three-fifths of the warrants cannot be exercised until after six months from issuance, or 61 days from issuance if the investor does not exercise its option to purchase the additional Series 1 Preferred Stock.

The Series 1 Preferred Stock is non-dividend bearing and has no voting rights except to the extent required by law.

Separately, the Company reacquired the remaining 100 outstanding shares ($100,000 stated value) of its Series A 3% Convertible Preferred Stock in exchange for 288,517 shares of common stock, and the Company has agreed to reacquire the remaining 1,000 outstanding shares ($1,000,000 stated value) of its Series D 7% Preferred Stock in exchange for shares of common stock based on a formula keyed to the volume-weighted average price over a 3-day period following April 13, 2009.

Upon completion of these exchanges, the only pre
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related biology technology :

1. Oxygen Biotherapeutics, Inc. CEO Posts New Blog Entry
2. Stockholder Suits Related to TorreyPines Therapeutics, Inc. Dismissed
3. Webcast Alert: Oxygen Biotherapeutics, Inc. Investor Meeting in Zurich, Switzerland
4. Oxygen Biotherapeutics, Inc. Adds Oxycyte TBI Clinical Trial Sites in Israel
5. Cell Therapeutics, Inc. Reports Outcome of Special Meeting of Shareholders
6. Cell Therapeutics, Inc. Special Meeting in Lieu of Annual Meeting of Shareholders Scheduled for Tuesday, March 24, 2009
7. Oxygen Biotherapeutics, Inc. Expands Board of Directors
8. Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results
9. Cell Therapeutics, Inc. (CTI) to Present at 8th Annual WBBA Invest Northwest Conference
10. Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End Financial Results on March 16
11. Cell Therapeutics, Inc. (CTI) BIO CEO Presentation to be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Every day, their baby stopped breathing, his collapsed bronchus ... April and Bryan Gionfriddo watched helplessly, just praying that ... few doctors said he had a good chance of ... her now 20-month-old son, Kaiba. "At that point, we ... it and run with it." , They found hope ...
(Date:5/23/2013)... CASTLE ROCK, Colo. , May 23, 2013 /PRNewswire/ ... vitro diagnostic company focused on obtaining FDA clearance ... APPY1 , today announced the pricing of an underwritten ... and related warrants to purchase 3,500,000 shares of its ... share at a combined public offering price of $1.25 ...
(Date:5/23/2013)... May 23, 2013  BioScrip, Inc. (NASDAQ: ... at the Jefferies 2013 Global Healthcare Conference to be ... York. Richard Smith , ... Tran , Chief Financial Officer, will present on ... Time.   About BioScrip BioScrip, Inc. ...
(Date:5/23/2013)... Can economic incentives such as gift ... of the public to increase their donations of blood? ... Carey Business School Assistant Professor Mario Macis says ... large body of recent research that supports their argument, ... issue of Science that the World Health Organization and ...
Breaking Biology Technology:Baby's life saved with groundbreaking 3-D printed device that restored his breathing 2Baby's life saved with groundbreaking 3-D printed device that restored his breathing 3Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3
... - Sonic Foundry, Inc. , has announced it ... shares of common stock at $3.75 per share. ... close on Dec. 27, 2006, will be used to ... the company's search technology and intellectual property protection. The ...
... segment of a national and international pipeline to Wisconsin might ... CellCura, Inc. , a Norwegian biotechnology and stem cell research ... Research Park . , ,CellCura, the fourth stem cell company ... years, chose Madison following an international search and will open ...
... TomoTherapy executives have talked about their ... are bearing fruit. , ,The Madison-based medical technology ... Kirloskar Theratronics, Ltd . to distribute ... countries. KTPL, part of the Kirloskar Group, provides ...
Cached Biology Technology:CellCura could start an invasion of stem cell firms 2CellCura could start an invasion of stem cell firms 3
(Date:5/23/2013)... in Plant Science , Automated ... content and promoter evolution among grasses , Within ... stretches of DNA that undergo little change in position ... code for any proteins. Some of these evolutionarily stable ... regulate the expression of other genes or the condensation ...
(Date:5/23/2013)... fruit, can be made both better-tasting and longer-lasting thanks ... "Working with GM tomatoes that are different to normal ... allows us to pinpoint exactly how to breed in ... Innes Centre. , The research could also lead to ... characteristics because even higher levels of the compounds can ...
(Date:5/23/2013)... Northwest National Laboratory honored more than 165 staff ... property at PNNL,s annual Intellectual Property Commercialization Recognition ... of Energy national laboratory named materials scientist Jun ... developing battery materials that can store large amounts ... and reduce the time it takes to charge ...
Breaking Biology News(10 mins):Frontiers news briefs: May 23 2Frontiers news briefs: May 23 3The world's favorite fruit only better-tasting and longer-lasting 2PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2
... the University of Cincinnati (UC) shows that high-fat diets, ... can inflame fat tissue surrounding blood vessels, possibly contributing ... in the Feb. 20 edition of the American Heart ... MD, and colleagues examined adipose tissueor fatsurrounding the coronary ...
... research trip to Puerto Rico, ecologist James Porter took samples ... evidence of radioactive matter instead he found a link ... life were to unexploded bombs from the World War II ... of carcinogenic materials. "Unexploded bombs are in the ...
... scientists claim that the degeneration of sight, caused by a ... by increasing the amount of fruit, vegetables and nuts in ... cause of blindness in the UK, with 45% of those ... results in a gradual loss of central vision, due to ...
Cached Biology News:High-fat diets inflame fat tissue around blood vessels, contribute to heart disease 2Link between unexploded munitions in oceans and cancer-causing toxins determined 2Diet could reduce onset of eye disease by 20 percent 2
Prepared with distilled water. Yeast extract solution is autolyzed at 150 g/L....
Request Info...
...
Geneticin Selective Antibiotic liquid...
Biology Products: